Treat overall risk rather than LDL, two doctors urge

01/26/2012 | TheHeart.org (Montreal) (free registration)

The national panel writing education and treatment guidelines on cholesterol should abandon low-density lipoprotein targets in favor of an approach that takes overall cardiovascular risk into account, two physicians write in a letter published in the journal Circulation: Cardiovascular Quality and Outcomes. "What we know is that statins reduce risk, but they ought to be concentrated in people at higher risk," said Dr. Harlan Krumholz of the Yale University School of Medicine.

View Full Article in:

TheHeart.org (Montreal) (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD